{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:13:19Z","timestamp":1762431199180,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,11,21]],"date-time":"2015-11-21T00:00:00Z","timestamp":1448064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["5P01HD032652"],"award-info":[{"award-number":["5P01HD032652"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.ymgmr.2015.11.004","type":"journal-article","created":{"date-parts":[[2016,8,13]],"date-time":"2016-08-13T17:18:12Z","timestamp":1471108692000},"page":"87-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Elements of lentiviral vector design toward gene therapy for treating mucopolysaccharidosis I"],"prefix":"10.1016","volume":"8","author":[{"given":"Li","family":"Ou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Przybilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda L.","family":"Koniar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chester B.","family":"Whitley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2015.11.004_bb0005","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.2174\/138161208784705504","article-title":"Lysosomal storage diseases and the blood\u2013brain barrier","volume":"14","author":"Begley","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3171\/FOC\/2008\/24\/3-4\/E11","article-title":"Central nervous system therapy for lysosomal storage disorders","volume":"24","author":"Enns","year":"2008","journal-title":"Neurosurg. Focus."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.nbd.2011.02.015","article-title":"Direct gene transfer to the CNS prevents emergence of neurologic disease in a murine model of mucopolysaccharidosis type I","volume":"43","author":"Wolf","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0020","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ymgme.2013.09.008","article-title":"High-dose enzyme replacement therapy in murine Hurler syndrome","volume":"11","author":"Ou","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-3476(98)70201-X","article-title":"Follow-up of nine patients with Hurler syndrome after bone marrow transplantation","volume":"133","author":"Guffon","year":"1998","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0030","first-page":"7","article-title":"Bone marrow transplantation for Hurler syndrome: assessment of metabolic correction","volume":"22","author":"Whitley","year":"1986","journal-title":"Birth Defects Orig. Artic. Ser."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0035","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ajmg.1320460222","article-title":"Long-term outcome of Hurler syndrome following bone marrow transplantation","volume":"46","author":"Whitley","year":"1993","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0040","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/hum.2005.16.81","article-title":"Gene therapy for a mucopolysaccharidosis type I murine model with lentiviral-IDUA vector","volume":"16","author":"Di Domenico","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0045","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ymthe.2004.08.027","article-title":"Liver-directed neonatal gene therapy prevents cardiac, bone, ear, and eye disease in mucopolysaccharidosis I mice","volume":"11","author":"Liu","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0050","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/sj.mt.6300201","article-title":"Correction of clinical manifestations of canine mucopolysaccharidosis I with neonatal retroviral vector gene therapy","volume":"15","author":"Traas","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0055","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1089\/hum.2006.17.1112","article-title":"Limited transgene immune response and long-term expression of human alpha-l-iduronidase in young adult mice with mucopolysaccharidosis type I by liver-directed gene therapy","volume":"17","author":"Di Domenico","year":"2006","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0060","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ymthe.2004.10.006","article-title":"Neonatal gene therapy of MPS I mice by intravenous injection of a lentiviral vector","volume":"11","author":"Kobayashi","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0065","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/ana.20150","article-title":"Prevention of neuropathology in the mouse model of Hurler syndrome","volume":"56","author":"Desmaris","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0070","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/mt.2010.265","article-title":"Safe, efficient, and reproducible gene therapy of the brain in the dog models of Sanfilippo and Hurler syndromes","volume":"19","author":"Ellinwood","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0075","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ana.20870","article-title":"Gene therapy of the brain in the dog model of Hurler's syndrome","volume":"60","author":"Ciron","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0080","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/mt.2009.87","article-title":"Systemic correction of storage disease in MPS I NOD\/SCID mice using the sleeping beauty transposon system","volume":"17","author":"Aronovich","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0085","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/mt.2008.119","article-title":"Targeting of the CNS in MPS-IH using a nonviral transferrin-alpha-l-iduronidase fusion gene product","volume":"16","author":"Osborn","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0090","first-page":"3459","article-title":"Retrovirus-mediated gene transfer of human adenosine deaminase: expression of functional enzyme in murine hematopoietic stem cells in vivo","volume":"7","author":"Lim","year":"1987","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0095","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1182\/blood.V86.11.4124.bloodjournal86114124","article-title":"Dysregulated expression of GATA-1 following retrovirus-mediated gene transfer into murine hematopoietic stem cells increases erythropoiesis","volume":"86","author":"Farina","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0100","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.4049\/jimmunol.158.2.1006","article-title":"Reversal of 1,3-bis(2-chloroethyl)-1-nitrosoureainduced severe immunodeficiency by transduction of murine long-lived hemopoietic progenitor cells using O6-methylguanine DNA methyltransferase complementary DNA","volume":"158","author":"Maze","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jjcc.2010.08.003","article-title":"Promoter-specific lentivectors for long-term, cardiac-directed therapy of Fabry disease","volume":"57","author":"Lee","year":"2011","journal-title":"J. Cardiol."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0110","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3727\/096368910X522117","article-title":"Long-term contribution of human bone marrow mesenchymal stromal cells to skeletal muscle regeneration in mice","volume":"20","author":"de la Garza-Rodea","year":"2011","journal-title":"Cell Transplant."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0115","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/sj.gt.3302309","article-title":"Self-inactivating retroviral vectors with improved RNA processing","volume":"11","author":"Kraunus","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0120","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/sj.gt.3302255","article-title":"B-cell-specific transgene expression using a self-inactivating retroviral vector with human CD19 promoter and viral post-transcriptional regulatory element","volume":"11","author":"Werner","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0125","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/sj.gt.3302698","article-title":"Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression","volume":"13","author":"Schambach","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0130","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1006\/mthe.2000.0191","article-title":"Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectors","volume":"2","author":"Schambach","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0135","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1182\/blood.V96.10.3392.h8003392_3392_3398","article-title":"High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors","volume":"96","author":"Salmon","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0140","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/sj.gt.3302979","article-title":"The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors","volume":"14","author":"Higashimoto","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0145","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/sj.mt.6300152","article-title":"Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors","volume":"15","author":"Schambach","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/sj.gt.3302417","article-title":"Potential oncogene activity of the woodchuck hepatitis post-transcriptional regulatory element (WPRE)","volume":"12","author":"Kingsman","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0155","doi-asserted-by":"crossref","first-page":"11382","DOI":"10.1073\/pnas.93.21.11382","article-title":"Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector","volume":"93","author":"Naldini","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0160","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1073\/pnas.252784899","article-title":"Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB","volume":"100","author":"Ohmi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0165","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ymgme.2013.11.009","article-title":"Standardization of \u03b1-l-iduronidase enzyme assay with Michaelis\u2013Menten kinetics","volume":"111","author":"Ou","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0170","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1128\/JVI.72.6.5085-5092.1998","article-title":"Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element","volume":"72","author":"Donello","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0175","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1089\/hum.1992.3.4-371","article-title":"Correction of mucopolysaccharidosis type I fibroblasts by retroviral-mediated transfer of the human alpha-l-iduronidase gene","volume":"3","author":"Anson","year":"1992","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0180","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jconrel.2012.05.018","article-title":"High levels of gene expression in the hepatocytes of adult mice, neonatal mice and tree shrews via retro-orbital sinus hydrodynamic injections of naked plasmid DNA","volume":"161","author":"Yan","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ymgmr.2015.11.004_bb0185","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1038\/sj.gt.3301298","article-title":"Retroviral vector design studies toward hematopoietic stem cell gene therapy for mucopolysaccharidosis type I","volume":"7","author":"Pan","year":"2000","journal-title":"Gene Ther."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426915300549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426915300549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:49:32Z","timestamp":1762001372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426915300549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":37,"alternative-id":["S2214426915300549"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2015.11.004","relation":{},"ISSN":["2214-4269"],"issn-type":[{"type":"print","value":"2214-4269"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elements of lentiviral vector design toward gene therapy for treating mucopolysaccharidosis I","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2015.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}